Glycated hemoglobin as a marker of dyslipidemia in type II Diabetic patients

Journal Title: International Journal of Medical and Dental Sciences - Year 2016, Vol 5, Issue 2

Abstract

Background: Diabetes is an important public health problem and leading cause of cardiovascular problems its early detection and good glycemic control can reduce the complications associated with the disease. Objective: This was a prospective study planned to evaluate the relationship of glycated haemoglobin (HbA1c) and lipid profile in type II diabetic Punjabi male population. Material and methods: A total of 200 diabetes type II patient ranging from age group of 30 to 70 years were included in the study after taking a preinformed written consent. The glycated haemoglobin (HbA1c) & lipid profile were performed on fully automated analyzers. The statistical analysis was done by using SPSS statistics and correlation among HbA1c and lipid profile of type II Diabetic patients was established. Results: The mean HbA1c was in the range of 7.54 ± 1.24%. There were 61% subjects with high total cholesterol (TC) levels and 96% were with raised LDL levels. The 68% of the subjects were having lower HDL level. HbA1c demonstrated significant positive relationship with total cholesterol, TC (r=0.995), triglyceride, TG (r=0.997), high density lipoprotein cholesterol, HDL-C (r=-0.940) and with low density lipoprotein cholesterol, LDL-C (r=0.993). Conclusion: The study concluded that HbA1c apart from acting as important diagnostic marker for glycemic control can also be used as a positive predictor of dyslipidemia in type 2 diabetics

Authors and Affiliations

Keywords

Related Articles

Idiopathic Epilepsies - A Population Based Epidemiologic Study

Background: There are only few epidemiological studies regarding epilepsy from this region. The classification of epilepsies has not been adequately stressed in these studies. Objective: To assess the occurrence of idio...

Central Giant Cell Granuloma: A Destructive Lesion

Central giant cell granuloma (CGCG) is a benign proliferation of fibroblasts and multinucleated giant cells that almost exclusively occurs within the jaw. It commonly occurs in the young adults showing a female predilect...

Prevalence of Thyroid Disorders in Patients of Type 2 Diabetes Mellitus

Background:Diabetes has become a major health challenge worldwide. Various studies have found that diabetes and thyroid disorders mutually influence each other and both disorders tend to coexist. Objective: To find out...

Cardiodepressant Activity of 90% Alcoholic Extract of Terminalia Arjuna and its Probable Mechanism of Action

Background:Terminalia arjuna is being used in various cardiovascular diseases as cardiotonic, diuretic&in hypercholesterolemia. Studies conflict each other for its mechanism of action. This study aims to investigate effe...

Download PDF file
  • EP ID EP481032
  • DOI 10.19056/ijmdsjssmes/2016/v5i2/100600
  • Views 60
  • Downloads 0

How To Cite

(2016). Glycated hemoglobin as a marker of dyslipidemia in type II Diabetic patients. International Journal of Medical and Dental Sciences, 5(2), 1164-1170. https://europub.co.uk/articles/-A-481032